Vaccinex (VCNX) Reports First Quarter 2019 Financial Results and Provides Corporate Update.

Updated interim data from CLASSICAL-Lung study to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in...
internet stock review

Innovus (INNV) Conference Call Today 5/15/19 at 4:15 EST.

The Company will host a conference call on Wednesday, May 15, 2019 at 4:15 p.m. ET/1:15 p.m. PT to discuss the financial...
biotech stock review, fluticare

Innovus (INNV): Twenty-Eight Drugs in Five Years. (San Diego Reader)

(Originally published 4/25/2018) “I am very steady. I like to work slowly, but surely, to get to my goal.”...
biotech stock review, innovus

Adding Innovus Pharma (INNV) $2.50 to Watch List.

Fast Growing eCommerce and Direct to Consumer Pharma Company Announces 1st Foray into CBD and 2nd Major Off-Patent Blockbuster Drug to its...
biotech stock review, zestra

Innovus Pharma (INNV) Partners With Lavasta’s 150 Member Sales Force for Female Sexual Arousal!

Dubai based Lavasta is a pharmaceutical marketing company that offers niched unique medications based on the latest scientific innovations that defy current...
candida auris, citius pharma, biotech stock review

Citius Pharma’s (CTXR) Mino-Lok® Highly Efficacious in Rapidly Eradicating Candida auris.

CRANFORD, N.J., May 13, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug...
Regoxidine, biotech stock review

Rogaine® Competitor Regoxidine™ Expected to Launch Second Half, 2019.

Innovus Pharma (INNV) Announces a Second Partnered United States OTC ANDA for Minoxidil 5% Foam for Men and Women.

3M to Acquire Wound Care Technology Co., Acelity for $6.7 Billion.

Chronic wounds represent a large and growing threat to public health. In the US alone, they affect over 6.5 million people. As...

Lift Off! Mustang Bio (MBIO) $9.31 Jumps 4-Fold.

‘Bubble Boy’ Biotech Soars 250 Percent After Cure Announcement (Bloomberg). (Bloomberg) -- Shares of the tiny biotechnology company...

Adding Vaccinex (VCNX) $5.50, to Watch List After Investor Presentation.

IPO Tumbles in Aftermarket, from $12 underwritten by Oppenheimer, BTIG and Ladenburg Thalmann, to a low of $3 in six months.

Latest article

Tiki Hut 7

Seven of the World’s Top Performing Stocks, Every Morning

THE TIKI HUT FUND | TODAY'S 7 BIGGEST MOVERS

Telehealth: iRhythm Technologies, Inc. (IRTC) Opening Down $43 (32%).

Let the dust settle or catch the falling knife? Down from a peak of $270, it's been a difficult...
CB Scientific, Biotech Stock Review, Telehealth

My-Cam™ and My-Cardia™ the Ultimate ‘Any-Doctor-Anywhere’ Telehealth Monitoring Application.

New and Updated Report on CB Scientific (CBSC) $1.05. Revolutionary Any-Doctor-Any Where, at Home Heart Rate Monitor, can...